Marché mondial de l'hydatidose - Tendances et prévisions de l'industrie jusqu'en 2029

Analyse et perspectives du marché mondial de l'hydatidose

Le marché de l'hydatidose devrait connaître une croissance exponentielle au cours de la période de prévision 2022-2029. Data Bridge Market Research analyse le marché pour s'attendre à une croissance à un TCAC de 6,30 % au cours de la période de prévision mentionnée ci-dessus.

L'hydatidose est un type de maladie parasitaire zoonotique provoquée par le ténia du chien Echinococcus et son stade larvaire. Elle se caractérise par la production de kystes de différentes tailles dans les organes viscéraux des hôtes intermédiaires et de ténias adultes dans les intestins des chiens. Cette affection est chronique et affecte à la fois les mammifères herbivores et omnivores, ainsi que tous les types d'animaux de rente. Elle est également connue sous le nom d'échinococcose kystique (EC).

L'augmentation de la prévalence de l'hydatidose sera un facteur majeur qui entraînera l'expansion de la croissance du marché. Un autre facteur important influençant le taux de croissance du marché de l'hydatidose est l'augmentation des dépenses de santé . En outre, les progrès de la technologie médicale, les initiatives croissantes des organisations publiques et privées pour sensibiliser et le financement croissant du gouvernement sont les facteurs qui développeront le marché de l'hydatidose. D'autres facteurs tels que l'augmentation de la demande de thérapies efficaces et l'augmentation de l'incidence des maladies parasitaires auront un impact positif sur le taux de croissance du marché de l'hydatidose. De plus, le revenu disponible élevé et l'évolution du mode de vie entraîneront l'expansion du marché de l'hydatidose. En outre, l'augmentation des approbations réglementaires pour les médicaments antiparasitaires renforcera la croissance du marché de l'hydatidose.

En outre, l’augmentation des activités de recherche et développement et le lancement de thérapies efficaces offriront des opportunités bénéfiques pour le marché de l’hydatidose au cours de la période de prévision de 2022 à 2029. En outre, les besoins non satisfaits élevés en matière de traitement actuel et les développements en matière de technologie des soins de santé augmenteront le taux de croissance du marché de l’hydatidose à l’avenir.

However, high cost associated with the treatment and lack of infrastructure in low-income countries will impede the growth rate of hydatidosis market. Additionally, complications involved with hydatidosis will hinder the hydatidosis market growth. Less awareness among rural population will further challenge the market in the forecast period mentioned above.

This hydatidosis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Hydatidosis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Hydatidosis Market Scope and Market Size

The hydatidosis market is segmented on the basis of treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the hydatidosis market is segmented into antiparasitic drugs, chemotherapy, cyst puncture, PAIR (percutaneous aspiration, injection of chemicals and reaspiration), surgery and others.
• On the basis of diagnosis, the hydatidosis market is segmented into blood tests, CT scans, ultrasonography, MRI and others.
• On the basis of dosage, the hydatidosis market is segmented into injection, tablets and others.
• On the basis of route of administration, the hydatidosis market is segmented into oral, intravenous and others.
• On the basis of symptoms, the hydatidosis market is segmented into bloody sputum, cough, chest pain, anaphylaxis and others.
• On the basis of end-users, the hydatidosis market is segmented into clinic, hospital and others.

The hydatidosis market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Hydatidosis Market Country Level Analysis

Hydatidosis market is analyzed and market size information is provided by the country, treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel as referenced above.

The countries covered in the hydatidosis market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the hydatidosis market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022 to 2029 due to the increasing patient pool, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Hydatidosis market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Hydatidosis Market Share Analysis

Hydatidosis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to hydatidosis market research.

Français Certains des principaux acteurs opérant sur le marché de l'hydatidose sont F. Hoffmann-La Roche Ltd., Novartis AG, AstraZeneca, Pfizer Inc., Sanofi, Bayer AG, Zydus Cadila, Merck KGaA, GlaxoSmithKline plc, Cipla Inc., Sun Pharmaceutical Industries Ltd., DAIICHI SANKYO COMPANY, LIMITED, Alvizia Healthcare Private Limited, Arbor Pharmaceuticals, Ipca Laboratories Ltd., Alkem Labs., Mallinckrodt, AJANTA PHARMA, Que Pharma Pvt. Ltd., Mankind Pharma et Mylan NV, entre autres.

SKU-67633